Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Bobulsky Susan sold 5,000 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Jun 11, 2026 · Filed Jun 15, 2026

On Jun 11, 2026, Bobulsky Susan (Chief Commercial Officer, MRD) sold 5,000 Adaptive Biotechnologies Corporation shares at US$19.00 for US$95,000 under a trading plan, leaving 411,775 shares. Filed Jun 15, 2026 (Form 4).

Sold
5,000 shares
Price
US$19.00
Value
US$95,000
Holding after
411,775 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer, MRD

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 11, 2026Common StockSale5,000US$19.00411,775Direct

Source

View original at SEC

Related